Rx “Tax Holiday” Nears President’s Desk Following House Passage
Executive Summary
A tax change that would allow U.S. pharmaceutical companies to pay a far lower duty to "repatriate" up to $500 mil. claimed by overseas affiliates remains en route to becoming law, despite objections raised by the Bush Administration
You may also be interested in...
Tight Credit Renews Interest In Lowering Tax On Repatriated Income
Billions of dollars held by pharmaceutical and other multinational companies in accounts outside the U.S. are being eyed as one remedy for tight credit markets
Tight Credit Renews Interest In Lowering Tax On Repatriated Income
Billions of dollars held by pharmaceutical and other multinational companies in accounts outside the U.S. are being eyed as one remedy for tight credit markets
Rx Firms Can Use Repatriated Cash On Marketing, Mergers
The Treasury Department and Internal Revenue Service will allow manufacturers to use repatriated cash from overseas operations on marketing expenses and mergers